Loading
Yanuki
ARTICLE DETAIL
Elizabeth Holmes Partner Launches AI Biotech Startup Haemanthus | Discord Outage Disrupts Services; Accenture Acquires Ookla to Enhance Network Intelligence | TCS Launches Gemini Experience Center in US with Google Cloud | Tencent QClaw Enables Dual Access to WeChat and QQ | OpenClaw AI Agents Surge in Popularity Amidst Security Concerns | Apple at 50: The Untold Story of the iPhone | Privacy Concerns Rise Over Meta's AI Smart Glasses | Apple Unveils MacBook Air with M5 Chip and Renames CPU Cores | TikTok Outage: Impact, Causes, and How Brands Can Prepare | Elizabeth Holmes Partner Launches AI Biotech Startup Haemanthus | Discord Outage Disrupts Services; Accenture Acquires Ookla to Enhance Network Intelligence | TCS Launches Gemini Experience Center in US with Google Cloud | Tencent QClaw Enables Dual Access to WeChat and QQ | OpenClaw AI Agents Surge in Popularity Amidst Security Concerns | Apple at 50: The Untold Story of the iPhone | Privacy Concerns Rise Over Meta's AI Smart Glasses | Apple Unveils MacBook Air with M5 Chip and Renames CPU Cores | TikTok Outage: Impact, Causes, and How Brands Can Prepare

Technology / Biotech

Elizabeth Holmes Partner Launches AI Biotech Startup Haemanthus

Billy Evans, the partner of disgraced Theranos founder Elizabeth Holmes, has secured millions in funding for a new artificial intelligence (AI) biotech startup named Haemanthus. Holmes, currently serving an 11-year prison sentence for defra...

Elizabeth Holmes' partner raises millions for new biotech testing startup
Share
X LinkedIn

elizabeth holmes
Elizabeth Holmes Partner Launches AI Biotech Startup Haemanthus Image via NPR

Key Insights

  • Haemanthus is a new biotech startup founded by Billy Evans, Elizabeth Holmes' partner, focusing on AI-driven medical testing.
  • Elizabeth Holmes, despite being in prison for fraud related to Theranos, is advising Evans on the startup.
  • The company is utilizing light detection technology and Raman spectroscopy for diagnostic testing, with potential applications in diagnosing diseases like ALS and cancer.
  • Haemanthus aims to make advanced medical testing technology more accessible and commercially available.

In-Depth Analysis

Haemanthus is in its early stages, focusing on using light detection technology to guide AI sensors for medical tests. The company's patent, granted in January, describes the tool's ability to test biological material like sweat, urine, saliva, and small blood samples.

The core technology revolves around Raman spectroscopy, a technique with proven applications in diagnosing conditions like ALS and cancer, and even detecting explosives. Haemanthus hopes to reduce the cost of this technology and make it accessible outside of research labs, developing consumer products for wider use.

Despite Holmes' involvement, Haemanthus faces the challenge of overcoming the negative perception associated with her and Theranos. The success of the company will depend on its ability to demonstrate the validity and reliability of its technology, while maintaining transparency and ethical practices.

Read source article

FAQ

What is Haemanthus?

Haemanthus is a biotech startup founded by Billy Evans that is focused on using AI and light detection technology for medical testing.

What is Elizabeth Holmes' role in Haemanthus?

Elizabeth Holmes is advising Billy Evans on the startup, despite serving a prison sentence for fraud.

What technology does Haemanthus use?

Haemanthus utilizes light detection technology and Raman spectroscopy for diagnostic testing.

Takeaways

  • Elizabeth Holmes is still indirectly involved in the biotech industry through her partner’s new venture.
  • Haemanthus aims to make advanced medical testing more accessible using AI and light detection.
  • The company faces the challenge of overcoming the negative reputation associated with Holmes and Theranos.

Discussion

What do you think about Elizabeth Holmes advising a new biotech startup while in prison? Share your thoughts in the comments below!

Share this article with others who need to stay ahead of this trend!

Sources

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.